Status:
COMPLETED
Covid-19 Pandemic and Pancreatic Surgery in Italy
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Pancreatic cancer (PC) is recognized as one of the most challenging tumors to deal with and it is still characterized by a poor long-term prognosis. However, treatment of PC in high-volume centers wit...
Eligibility Criteria
Inclusion
- all patients with a diagnosis of pancreatic cancer referred to one of the centers involved in the study during the two study periods
Exclusion
- patients under the age of 18
- inability to give informed consent
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
730 Patients enrolled
Trial Details
Trial ID
NCT04380766
Start Date
January 1 2019
End Date
July 31 2020
Last Update
August 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS di Roma
Rome, Lazio, Italy, 00168